Nicolet Advisory Services’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
Nicolet Advisory Services's DGX Position: Q4 2025 in Review
Nicolet Advisory Services reduced its Quest Diagnostics (DGX) stake by 18% in Q4 2025, selling an estimated $57.7K and leaving 1,479 shares worth $260K. The position accounts for 0.02% of the portfolio, ranked #353.
Nicolet Advisory Services first reported a position in DGX in Q4 2023 and has held it in 9 quarters since. The position peaked at $486K in Q2 2025. 1,048 funds tracked by Wall St. Rank hold DGX as of Q4 2025.
- Nicolet Advisory Services held 1,479 shares of Quest Diagnostics worth $260K as of Q4 2025.
- Nicolet Advisory Services sold 317 Quest Diagnostics shares in Q4 2025, an estimated $57.7K.
- Quest Diagnostics made up 0.02% of Nicolet Advisory Services's portfolio in Q4 2025, its #353 holding.
- Nicolet Advisory Services first reported a position in Quest Diagnostics in Q4 2023 and has held it in 9 quarters since.
- Nicolet Advisory Services's Quest Diagnostics position peaked at $486K in Q2 2025.
- 1,048 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2025.
Based on Nicolet Advisory Services's 13F filing for Q4 2025, filed 13 Feb 2026.